Pain without nociceptors? Nav1.7-independent pain mechanisms

Cell Reports

Volumn 6, Issue 2, 2014, Pages 301-312

  Minett, Michael S ^a   Falk, Sarah ^b   Santana Varela, Sonia ^a   Bogdanov, Yury D ^a   Nassar, Mohammed A ^a   Heegaard, Anne Marie ^b   Wood, John N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN; SODIUM CHANNEL NAV1.3; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL NAV1.9;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CANCER; BONE PAIN; CANCER PAIN; CHRONIC CONSTRICTION INJURY; CHRONIC PAIN; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; NERVE TRANSECTION; NEUROPATHIC PAIN; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; SENSORY NERVE CELL; SYMPATHETIC NERVE CELL;

MUS;

ANIMALS; HYPERALGESIA; MICE; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; NEURALGIA; NOCICEPTION; NOCICEPTIVE PAIN; NOCICEPTORS;

EID: 84893371465     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.12.033     Document Type: Article

References (68)

1. Abbadie C., Besson J.M. c-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 1992, 48:985-993.
2. Abrahamsen B., Zhao J., Asante C.O., Cendan C.M., Marsh S., Martinez-Barbera J.P., Nassar M.A., Dickenson A.H., Wood J.N. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 2008, 321:702-705.
3. Aguirre J., Del Moral A., Cobo I., Borgeat A., Blumenthal S. The role of continuous peripheral nerve blocks. Anesthesiol. Res. Pract. 2012, 2012:560879.
4. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 1999, 2:541-548.
5. Backonja M.M., Attal N., Baron R., Bouhassira D., Drangholt M., Dyck P.J., Edwards R.R., Freeman R., Gracely R., Haanpaa M.H., et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013, 154:1807-1819.
6. Baron R., Levine J.D., Fields H.L. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain?. Muscle Nerve 1999, 22:678-695.
7. Bautista D.M., Jordt S.-E., Nikai T., Tsuruda P.R., Read A.J., Poblete J., Yamoah E.N., Basbaum A.I., Julius D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124:1269-1282.
8. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
9. Bernardini C., Maggiolo F. Triple-combination rilpivirine, emtricitabine, and tenofovir (CompleraTM/EvipleraTM) in the treatment of HIV infection. Patient Prefer Adherence 2013, 7:531-542.
10. Bessou P., Perl E.R. Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli. J.Neurophysiol. 1969, 32:1025-1043.
11. Brumovsky P., Villar M.J., Hökfelt T. Tyrosine hydroxylase is expressed in a subpopulation of small dorsal root ganglion neurons in the adult mouse. Exp. Neurol. 2006, 200:153-165.
12. Burgess P.R., Perl E.R. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J.Physiol. 1967, 190:541-562.
13. Campbell J.N., Meyer R.A. Mechanisms of neuropathic pain. Neuron 2006, 52:77-92.
14. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J.Neurosci. Methods 1994, 53:55-63.
15. Clohisy D.R., Palkert D., Ramnaraine M.L., Pekurovsky I., Oursler M.J. Human breast cancer induces osteoclast activation and increases thenumber of osteoclasts at sites of tumor osteolysis. J.Orthop. Res. 1996, 14:396-402.
16. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444:894-898.
17. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
18. Descoeur J., Pereira V., Pizzoccaro A., Francois A., Ling B., Maffre V., Couette B., Busserolles J., Courteix C., Noel J., et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 2011, 3:266-278.
19. Deuis J.R., Zimmermann K., Romanovsky A.A., Possani L.D., Cabot P.J., Lewis R.J., Vetter I. An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways. Pain 2013, 154:1749-1757.
20. Egashira N., Hirakawa S., Kawashiri T., Yano T., Ikesue H., Oishi R. Mexiletine reverses oxaliplatin-induced neuropathic pain in rats. J.Pharmacol. Sci. 2010, 112:473-476.
21. Eijkelkamp N., Linley J.E., Baker M.D., Minett M.S., Cregg R., Werdehausen R., Rugiero F., Wood J.N. Neurological perspectives on voltage-gated sodium channels. Brain 2012, 135:2585-2612.
22. Eijkelkamp N., Linley J.E., Torres J.M., Bee L., Dickenson A.H., Gringhuis M., Minett M.S., Hong G.S., Lee E., Oh U., et al. A role for Piezo2 in EPAC1-dependent mechanical allodynia. Nat Commun 2013, 4:1682.
23. Falk S., Uldall M., Heegaard A.-M. The role of purinergic receptors in cancer-induced bone pain. J.Osteoporos. 2012, 2012:758181.
24. Falk S., Uldall M., Appel C., Ding M., Heegaard A.-M. Influence of sex differences on the progression of cancer-induced bone pain. Anticancer Res. 2013, 33:1963-1969.
25. García-Poblete E., Fernández-García H., Moro-Rodríguez E., Catalá-Rodríguez M., Rico-Morales M.L., García-Gómez-de-las-Heras S., Palomar-Gallego M.A. Sympathetic sprouting in dorsal root ganglia (DRG): a recent histological finding?. Histol. Histopathol. 2003, 18:575-586.
26. Gasser H.S. The classification of nerve fibers. Ohio J. Sci. 1941, 41:145-159.
27. Goldberg Y.P., MacFarlane J., MacDonald M.L., Thompson J., Dube M.P., Mattice M., Fraser R., Young C., Hossain S., Pape T., et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet. 2007, 71:311-319.
28. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000, 98:585-598.
29. Ke C.B., He W.S., Li C.J., Shi D., Gao F., Tian Y.K. Enhanced SCN7A/Nax expression contributes to bone cancer pain by increasing excitability of neurons in dorsal root ganglion. Neuroscience 2012, 227:80-89.
30. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
31. Kim K.J., Yoon Y.W., Chung J.M. Comparison of three rodent neuropathic pain models. Exp. Brain Res. 1997, 113:200-206.
32. Kinnane N. Burden of bone disease. Eur. J. Oncol. Nurs. 2007, 11(Suppl 2):S28-S31.
33. Lagerström M.C., Rogoz K., Abrahamsen B., Persson E., Reinius B., Nordenankar K., Olund C., Smith C., Mendez J.A., Chen Z.-F., et al. VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch. Neuron 2010, 68:529-542.
34. Lagerström M.C., Rogoz K., Abrahamsen B., Lind A.-L., Olund C., Smith C., Mendez J.A., Wallén-Mackenzie Å., Wood J.N., Kullander K. A sensory subpopulation depends on vesicular glutamate transporter 2 for mechanical pain, and together with substance P, inflammatory pain. Proc. Natl. Acad. Sci. USA 2011, 108:5789-5794.
35. Lallemend F., Ernfors P. Molecular interactions underlying the specification of sensory neurons. Trends Neurosci. 2012, 35:373-381.
36. Lau J., Minett M.S., Zhao J., Dennehy U., Wang F., Wood J.N., Bogdanov Y.D. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Mol. Pain 2011, 7:100.
37. Leo N.A., Callahan T.A., Bonneau R.H. Peripheral sympathetic denervation alters both the primary and memory cellular immune responses to herpes simplex virus infection. Neuroimmunomodulation 1998, 5:22-35.
38. Liu X., Chung K., Chung J.M. Ectopic discharges and adrenergic sensitivity of sensory neurons after spinal nerve injury. Brain Res. 1999, 849:244-247.
39. López-Álvarez S., Mayo-Moldes M., Zaballos M., Iglesias B.G., Blanco-Dávila R. Esmolol versus ketamine-remifentanil combination for early postoperative analgesia after laparoscopic cholecystectomy: a randomized controlled trial. Can. J. Anaesth. 2012, 59:442-448.
40. Maratou K., Wallace V.C.J., Hasnie F.S., Okuse K., Hosseini R., Jina N., Blackbeard J., Pheby T., Orengo C., Dickenson A.H., et al. Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur. J. Pain 2009, 13:387-398.
41. McLachlan E.M., Jänig W., Devor M., Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993, 363:543-546.
42. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997, 69:1-18.
43. Minett M.S., Nassar M.A., Clark A.K., Passmore G., Dickenson A.H., Wang F., Malcangio M., Wood J.N. Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun 2012, 3:791-799.
44. Mishra S.K., Tisel S.M., Orestes P., Bhangoo S.K., Hoon M.A. TRPV1-lineage neurons are required for thermal sensation. EMBO J. 2011, 30:582-593.
45. Müller J. Elements of Physiology 1842, Taylor and Walton, London.
46. Nassar M.A., Stirling L.C., Forlani G., Baker M.D., Matthews E.A., Dickenson A.H., Wood J.N. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl. Acad. Sci. USA 2004, 101:12706-12711.
47. Nassar M.A., Levato A., Stirling L.C., Wood J.N. Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol. Pain 2005, 1:24.
48. Nassar M.A., Baker M.D., Levato A., Ingram R., Mallucci G., McMahon S.B., Wood J.N. Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol. Pain 2006, 2:33.
49. Ostman J.A., Nassar M.A., Wood J.N., Baker M.D. GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J.Physiol. 2008, 586:1077-1087.
50. Ramer M.S., Bisby M.A. Sympathetic axons surround neuropeptide-negative axotomized sensory neurons. Neuroreport 1998, 9:3109-3113.
51. Ramer M.S., Bisby M.A. Normal and injury-induced sympathetic innervation of rat dorsal root ganglia increases with age. J.Comp. Neurol. 1998, 394:38-47.
52. Ramer M.S., Bisby M.A. Differences in sympathetic innervation of mouse DRG following proximal or distal nerve lesions. Exp. Neurol. 1998, 152:197-207.
53. Renn C.L., Carozzi V.A., Rhee P., Gallop D., Dorsey S.G., Cavaletti G. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol. Pain 2011, 7:29.
54. Roberts W.J. A hypothesis on the physiological basis for causalgia and related pains. Pain 1986, 24:297-311.
55. Roberts W.J., Foglesong M.E. Spinal recordings suggest that wide-dynamic-range neurons mediate sympathetically maintained pain. Pain 1988, 34:289-304.
56. Schmalhofer W.A., Calhoun J., Burrows R., Bailey T., Kohler M.G., Weinglass A.B., Kaczorowski G.J., Garcia M.L., Koltzenburg M., Priest B.T. ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors. Mol. Pharmacol. 2008, 74:1476-1484.
57. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J.Neurosci. 1999, 19:10886-10897.
58. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43:205-218.
59. Shields S.D., Ahn H.-S., Yang Y., Han C., Seal R.P., Wood J.N., Waxman S.G., Dib-Hajj S.D. Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. Pain 2012, 153:2017-2030.
60. Sittl R., Lampert A., Huth T., Schuy E.T., Link A.S., Fleckenstein J., Alzheimer C., Grafe P., Carr R.W. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current. Proc. Natl. Acad. Sci. USA 2012, 109:6704-6709.
61. Torebjörk E., Wahren L., Wallin G., Hallin R., Koltzenburg M. Noradrenaline-evoked pain in neuralgia. Pain 1995, 63:11-20.
62. Velasco R., Bruna J. [Chemotherapy-induced peripheral neuropathy: an unresolved issue]. Neurologia 2010, 25:116-131.
63. Vrontou S., Wong A.M., Rau K.K., Koerber H.R., Anderson D.J. Genetic identification of C fibres that detect massage-like stroking of hairy skininvivo. Nature 2013, 493:669-673.
64. Wagner R., DeLeo J.A., Coombs D.W., Willenbring S., Fromm C. Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res. 1993, 629:323-326.
65. Waxman S.G. Painful Na-channelopathies: an expanding universe. Trends Mol. Med. 2013, 19:406-409.
66. Xie W., Strong J.A., Zhang J.-M. Increased excitability and spontaneous activity of rat sensory neurons following invitro stimulation of sympathetic fiber sprouts in the isolated dorsal root ganglion. Pain 2010, 151:447-459.
67. Xie W., Strong J.A., Mao J., Zhang J.-M. Highly localized interactions between sensory neurons and sprouting sympathetic fibers observed in a transgenic tyrosine hydroxylase reporter mouse. Mol. Pain 2011, 7:53.
68. Zariwala H.A., Borghuis B.G., Hoogland T.M., Madisen L., Tian L., De Zeeuw C.I., Zeng H., Looger L.L., Svoboda K., Chen T.W. ACre-dependent GCaMP3 reporter mouse for neuronal imaging invivo. J.Neurosci. 2012, 32:3131-3141.